I do think there are some firms that have the skill to out-perform long term, but then the average is dragged down by ones like the subject of this article.
As for the strategy, that's the idea but all of them market themselves on the returns first and foremost.
Using leverage has risks that you're supposed to understand before you do it.
It's not a free lunch, unless you're putting the sharks' interest ahead of yours. Or clueless, which was the case here, as L.A. is not a trader and has no business running a fund.
The arguments against him barely hold water in general anyway.
This has nothing to do with what people actually hate him for, and for which he was not convicted, because extracting money from a captive clientele is exactly what the US healthcare system is designed to do.
His investor literacy youtube backlog is unusually deep and as of yet has only shilled his own trading product.
But your point is valid, he will never live down the fraud conviction and his face is so punchable.
If you've a better source, share it; I'll have a look and might use that one in the future. Otherwise, if you can't contribute in a constructive manner, stop making baseless comments about others intention without understanding them first.
he's a relatively well known figure in finance and pharma investing
Edit: I don't do podcasts but this is absolutely worth some of your time to watch.